Page last updated: 2024-12-07

24,25-epoxycholesterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

24,25-epoxycholesterol: Rn given refers to (3alpha,5beta)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

24(S),25-epoxycholesterol : A 3beta-hydroxy-Delta(5)-steroid that is desmosterol in which the double bond at position 24-25 has been oxidised to the corresponding epoxide (the 24S diastereoisomer). It is an oxysterol agonist of the liver X receptor. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3247059
CHEMBL ID434302
CHEBI ID41633
SCHEMBL ID926574
MeSH IDM0091365

Synonyms (33)

Synonym
(3s,8s,9s,10r,13r,14s,17r)-17-[(2r)-4-[(2s)-3,3-dimethyloxiran-2-yl]butan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-ol
gtpl2751
77058-74-3
24(s),25-epoxycholesterol
SPECTRUM5_001979 ,
24s,25-epoxy-cholest-5-en-3beta-ol
24s,25-epoxy-cholesterol
LMST01010012
24,25-epoxy-cholesterol
bdbm20164
chembl434302 ,
(1s,2r,5s,10s,11s,14r,15r)-14-[(2r)-4-[(2s)-3,3-dimethyloxiran-2-yl]butan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-7-en-5-ol
24,25(s)-epoxycholesterol
24,25-epoxycholesterol
chebi:41633 ,
24(s), 25-epoxycholesterol
BRD-K61480498-001-01-2
(8s,9s,10r,13r,14s,17r)-17-((r)-4-((s)-3,3-dimethyloxiran-2-yl)butan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol
SCHEMBL926574
(24s)-24,25-epoxycholesterol
(3beta,24s)-24,25-epoxycholest-5-en-3-ol
(24s)-25-epoxycholesterol
24(s),25-ec
(24s)-24,25-epoxycholest-5-en-3beta-ol
DTXSID30390608
OSENKJZWYQXHBN-XVYZBDJZSA-N
(3beta,14beta,24s)-24,25-epoxycholest-5-en-3-ol
lopenta[a]phenanthren-3-ol
17-[3-(3,3-dimethyl-oxiranyl)-1-methyl-propyl]-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyc
Q27071872
(24s,25)-epoxycholesterol
24(s),25-epoxycholesterol (not deuterated)
PD015544

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" After oral dosing at 10 mg/kg to C57BL/6 mice, 12 increased expression of the reverse cholesterol transporter ABCA1 in the small intestine and peripheral macrophages and increased the plasma concentrations of HDL cholesterol by 30%."( Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
Beaudet, EJ; Binz, JG; Collins, JL; Fivush, AM; Galardi, CM; Kliewer, SA; Lewis, MC; Moore, LB; Morgan, DG; Parks, DJ; Plunket, KD; Tippin, TK; Watson, MA; Whitney, KD; Willson, TM; Wilson, JG, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
liver X receptor agonistAny compound that acts as an agonist towards the liver X receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cholestanoidAny steroid based on a cholestane skeleton and its derivatives.
3beta-hydroxy-Delta(5)-steroidAny 3beta-hydroxy-steroid that contains a double bond between positions 5 and 6.
epoxy steroidAny steroid whose structure includes an epoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways039
Cholesterol biosynthesis pathway in hepatocytes1137
Sterols biosynthesis pathway015

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Oxysterols receptor LXR-betaHomo sapiens (human)EC50 (µMol)5.21350.00010.40077.3000AID1304660; AID1304662; AID418425; AID418427
Oxysterols receptor LXR-alphaHomo sapiens (human)EC50 (µMol)2.77860.00010.63026.7100AID101835; AID101836; AID101837; AID1304659; AID1304661; AID1797958; AID1797959; AID262339; AID418426
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (43)

Processvia Protein(s)Taxonomy
hormone-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipid storageOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-betaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-betaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-betaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-betaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of high-density lipoprotein particle assemblyOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of pancreatic juice secretionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of secretion of lysosomal enzymesOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of miRNA transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-betaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-alphaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transporter activityOxysterols receptor LXR-alphaHomo sapiens (human)
response to progesteroneOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of toll-like receptor 4 signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
regulation of circadian rhythmOxysterols receptor LXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage activationOxysterols receptor LXR-alphaHomo sapiens (human)
apoptotic cell clearanceOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of inflammatory responseOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-alphaHomo sapiens (human)
lipid homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
sterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
triglyceride homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
cellular response to lipopolysaccharideOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pancreatic juice secretionOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of secretion of lysosomal enzymesOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-alphaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
protein bindingOxysterols receptor LXR-betaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-betaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
apolipoprotein A-I receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear retinoid X receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
ATPase bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-betaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-alphaHomo sapiens (human)
protein bindingOxysterols receptor LXR-alphaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol bindingOxysterols receptor LXR-alphaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
sterol response element bindingOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytosolOxysterols receptor LXR-betaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-betaHomo sapiens (human)
chromatinOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytosolOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-alphaHomo sapiens (human)
chromatinOxysterols receptor LXR-alphaHomo sapiens (human)
receptor complexOxysterols receptor LXR-alphaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (36)

Assay IDTitleYearJournalArticle
AID1346993Human Liver X receptor-beta (1H. Liver X receptor-like receptors)2013Nature chemical biology, Feb, Volume: 9, Issue:2
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.
AID1346755Human Liver X receptor-alpha (1H. Liver X receptor-like receptors)1997The Journal of biological chemistry, Feb-07, Volume: 272, Issue:6
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway.
AID1346755Human Liver X receptor-alpha (1H. Liver X receptor-like receptors)1999Proceedings of the National Academy of Sciences of the United States of America, Jan-05, Volume: 96, Issue:1
Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta.
AID1346755Human Liver X receptor-alpha (1H. Liver X receptor-like receptors)2013Nature chemical biology, Feb, Volume: 9, Issue:2
Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.
AID1346993Human Liver X receptor-beta (1H. Liver X receptor-like receptors)1997The Journal of biological chemistry, Feb-07, Volume: 272, Issue:6
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway.
AID101844Tested for its ability to activate Liver X receptor-alpha expressed as Relative efficacy determined by maximal increase in relative fluorescence in LiSA2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.
AID418426Agonist activity at LXRalpha ligand binding domain by FRET based SRC1 recruitment assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
AID1304660Binding to human LXRbeta2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
AID331160Induction of Cox2 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID101837Effective concentration in LXR alpha-Gal4 receptor gene assay2002Journal of medicinal chemistry, May-09, Volume: 45, Issue:10
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
AID331161Induction of ACTB gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331152Induction of ABCA1 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331159Induction of IL6 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331154Induction of APOE gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID1304661Agonist activity at human LXRalpha coexpressed in African green monkey CV1 cells by Gal4 responsive reporter gene assay2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
AID331153Induction of ABCG1 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331158Induction of HDS11B1 gene expression in human THP1 cells at 10 uM using Array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331155Induction of SREBP1c gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID1304659Binding affinity to human LXRalpha2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
AID101836Ligand-dependent recruitment of steroid receptor co-activator 1 (SRC1) to Liver X receptor-alpha2002Journal of medicinal chemistry, May-09, Volume: 45, Issue:10
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
AID331151Induction of LXRalpha gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID331157Induction of SCD1 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID101835Concentration required for half maximal activity was calculated in human nuclear oxysterol receptor liver X receptor-alpha in LiSA.2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.
AID331162Induction of B2M gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID418705Agonist activity at human LXRalpha expressed in human SH-SY5Y cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
AID331156Induction of FASN gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID101843Relative efficacy compared to 24(S),25-epoxy cholesterol in Liver X receptor-alpha ligand-sensing assay2002Journal of medicinal chemistry, May-09, Volume: 45, Issue:10
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
AID101842Relative efficacy compared to 24(S),25-epoxy cholesterol in LXR alpha-Gal4 receptor gene assay2002Journal of medicinal chemistry, May-09, Volume: 45, Issue:10
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
AID331163Induction of TBP gene expression in human THP1 cells at 10 uM using by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID262339Activity against LXR alpha transiently transfected in HEK293 cells2006Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
Discovery and optimization of a novel series of liver X receptor-alpha agonists.
AID418427Agonist activity at human LXRbeta expressed in human SH-SY5Y cells co-transfected with Gal4-LBD after 24 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
AID331150Induction of NR1H2 gene expression in human THP1 cells at 10 uM by array plate mRNA assay2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
AID418425Agonist activity at LXRbeta ligand binding domain by FRET based SRC1 recruitment assay2009Bioorganic & medicinal chemistry letters, Apr-01, Volume: 19, Issue:7
Liver X receptor agonists with selectivity for LXRbeta; N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides.
AID1304662Agonist activity at human LXRbeta coexpressed in African green monkey CV1 cells by Gal4 responsive reporter gene assay2016Journal of medicinal chemistry, Apr-14, Volume: 59, Issue:7
Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
AID1797959Cell-Free Ligand Sensing Assay (LiSA)-LXRalpha-SRC1 Assay from Article 10.1021/jm0004749: \\Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.\\2001Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6
Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.
AID1797958Cell-Free Ligand Sensing Assay (LiSA)-LXRalpha-SRC1 Assay from Article 10.1021/jm0255116: \\Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.\\2002Journal of medicinal chemistry, May-09, Volume: 45, Issue:10
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (14.29)18.7374
1990's5 (7.94)18.2507
2000's28 (44.44)29.6817
2010's17 (26.98)24.3611
2020's4 (6.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (10.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (89.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]